498 related articles for article (PubMed ID: 16904556)
1. EUK-8, a superoxide dismutase and catalase mimetic, reduces cardiac oxidative stress and ameliorates pressure overload-induced heart failure in the harlequin mouse mutant.
van Empel VP; Bertrand AT; van Oort RJ; van der Nagel R; Engelen M; van Rijen HV; Doevendans PA; Crijns HJ; Ackerman SL; Sluiter W; De Windt LJ
J Am Coll Cardiol; 2006 Aug; 48(4):824-32. PubMed ID: 16904556
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of apoptosis-inducing factor in harlequin mutant mice sensitizes the myocardium to oxidative stress-related cell death and pressure overload-induced decompensation.
van Empel VP; Bertrand AT; van der Nagel R; Kostin S; Doevendans PA; Crijns HJ; de Wit E; Sluiter W; Ackerman SL; De Windt LJ
Circ Res; 2005 Jun; 96(12):e92-e101. PubMed ID: 15933268
[TBL] [Abstract][Full Text] [Related]
3. Antioxidant therapy attenuates myocardial telomerase activity reduction in superoxide dismutase-deficient mice.
Makino N; Maeda T; Oyama J; Sasaki M; Higuchi Y; Mimori K; Shimizu T
J Mol Cell Cardiol; 2011 Apr; 50(4):670-7. PubMed ID: 21195081
[TBL] [Abstract][Full Text] [Related]
4. Heart tissue of harlequin (hq)/Big Blue mice has elevated reactive oxygen species without significant impact on the frequency and nature of point mutations in nuclear DNA.
Crabbe RA; Hill KA
Mutat Res; 2010 Sep; 691(1-2):64-71. PubMed ID: 20541563
[TBL] [Abstract][Full Text] [Related]
5. Apoptosis-inducing factor is a major contributor to neuronal loss induced by neonatal cerebral hypoxia-ischemia.
Zhu C; Wang X; Huang Z; Qiu L; Xu F; Vahsen N; Nilsson M; Eriksson PS; Hagberg H; Culmsee C; Plesnila N; Kroemer G; Blomgren K
Cell Death Differ; 2007 Apr; 14(4):775-84. PubMed ID: 17039248
[TBL] [Abstract][Full Text] [Related]
6. Poly(ADP-Ribose) polymerase promotes cardiac remodeling, contractile failure, and translocation of apoptosis-inducing factor in a murine experimental model of aortic banding and heart failure.
Xiao CY; Chen M; Zsengellér Z; Li H; Kiss L; Kollai M; Szabó C
J Pharmacol Exp Ther; 2005 Mar; 312(3):891-8. PubMed ID: 15523000
[TBL] [Abstract][Full Text] [Related]
7. Practical prevention of cardiac remodeling and atrial fibrillation with full-spectrum antioxidant therapy and ancillary strategies.
McCarty MF
Med Hypotheses; 2010 Aug; 75(2):141-7. PubMed ID: 20083360
[TBL] [Abstract][Full Text] [Related]
8. Attenuation of staurosporine-induced apoptosis, oxidative stress, and mitochondrial dysfunction by synthetic superoxide dismutase and catalase mimetics, in cultured cortical neurons.
Pong K; Doctrow SR; Huffman K; Adinolfi CA; Baudry M
Exp Neurol; 2001 Sep; 171(1):84-97. PubMed ID: 11520123
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of mitochondrial peroxiredoxin-3 prevents left ventricular remodeling and failure after myocardial infarction in mice.
Matsushima S; Ide T; Yamato M; Matsusaka H; Hattori F; Ikeuchi M; Kubota T; Sunagawa K; Hasegawa Y; Kurihara T; Oikawa S; Kinugawa S; Tsutsui H
Circulation; 2006 Apr; 113(14):1779-86. PubMed ID: 16585391
[TBL] [Abstract][Full Text] [Related]
10. Apoptosis-inducing factor regulates skeletal muscle progenitor cell number and muscle phenotype.
Armand AS; Laziz I; Djeghloul D; Lécolle S; Bertrand AT; Biondi O; De Windt LJ; Chanoine C
PLoS One; 2011; 6(11):e27283. PubMed ID: 22076146
[TBL] [Abstract][Full Text] [Related]
11. The harlequin mouse mutation downregulates apoptosis-inducing factor.
Klein JA; Longo-Guess CM; Rossmann MP; Seburn KL; Hurd RE; Frankel WN; Bronson RT; Ackerman SL
Nature; 2002 Sep; 419(6905):367-74. PubMed ID: 12353028
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial oxidative stress and dysfunction in myocardial remodelling.
Tsutsui H; Kinugawa S; Matsushima S
Cardiovasc Res; 2009 Feb; 81(3):449-56. PubMed ID: 18854381
[TBL] [Abstract][Full Text] [Related]
13. K(ATP) activation prevents progression of cardiac hypertrophy to failure induced by pressure overload via protecting endothelial function.
Gao S; Long CL; Wang RH; Wang H
Cardiovasc Res; 2009 Aug; 83(3):444-56. PubMed ID: 19304734
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of NADPH oxidase reduces myocardial oxidative stress and apoptosis and improves cardiac function in heart failure after myocardial infarction.
Qin F; Simeone M; Patel R
Free Radic Biol Med; 2007 Jul; 43(2):271-81. PubMed ID: 17603936
[TBL] [Abstract][Full Text] [Related]
15. EGCG inhibits cardiomyocyte apoptosis in pressure overload-induced cardiac hypertrophy and protects cardiomyocytes from oxidative stress in rats.
Sheng R; Gu ZL; Xie ML; Zhou WX; Guo CY
Acta Pharmacol Sin; 2007 Feb; 28(2):191-201. PubMed ID: 17241521
[TBL] [Abstract][Full Text] [Related]
16. Different extent of cardiac malfunction and resistance to oxidative stress in heterozygous and homozygous manganese-dependent superoxide dismutase-mutant mice.
Loch T; Vakhrusheva O; Piotrowska I; Ziolkowski W; Ebelt H; Braun T; Bober E
Cardiovasc Res; 2009 Jun; 82(3):448-57. PubMed ID: 19293248
[TBL] [Abstract][Full Text] [Related]
17. Mineralocorticoid receptor inhibition ameliorates the transition to myocardial failure and decreases oxidative stress and inflammation in mice with chronic pressure overload.
Kuster GM; Kotlyar E; Rude MK; Siwik DA; Liao R; Colucci WS; Sam F
Circulation; 2005 Feb; 111(4):420-7. PubMed ID: 15687129
[TBL] [Abstract][Full Text] [Related]
18. Taurine supplementation reduces oxidative stress and improves cardiovascular function in an iron-overload murine model.
Oudit GY; Trivieri MG; Khaper N; Husain T; Wilson GJ; Liu P; Sole MJ; Backx PH
Circulation; 2004 Apr; 109(15):1877-85. PubMed ID: 15037530
[TBL] [Abstract][Full Text] [Related]
19. The I{kappa}B kinase {beta}/nuclear factor {kappa}B signaling pathway protects the heart from hemodynamic stress mediated by the regulation of manganese superoxide dismutase expression.
Hikoso S; Yamaguchi O; Nakano Y; Takeda T; Omiya S; Mizote I; Taneike M; Oka T; Tamai T; Oyabu J; Uno Y; Matsumura Y; Nishida K; Suzuki K; Kogo M; Hori M; Otsu K
Circ Res; 2009 Jul; 105(1):70-9. PubMed ID: 19478205
[TBL] [Abstract][Full Text] [Related]
20. Transgenic expression of matrix metalloproteinase-1 inhibits myocardial fibrosis and prevents the transition to heart failure in a pressure overload mouse model.
Foronjy RF; Sun J; Lemaitre V; D'Armiento JM
Hypertens Res; 2008 Apr; 31(4):725-35. PubMed ID: 18633185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
